Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses2 min read . Updated: 15 Sep 2020, 05:00 PM IST
- As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate
- US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus
Novavax Inc today announced that it has revised its deal with world's largest vaccine manufacturing company Serum Institute of India (SII) in order to produce 2 billion doses of Covid-19 vaccines.
Select your Category